Molecular biomarkers for Alzheimer’s disease and related dementias – improved methods to facilitate global studies

Henrik Zetterberg · 2025

Read Molecular biomarkers for Alzheimer’s disease and related dementias – improved methods to facilitate global studies by Henrik Zetterberg (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11715700.txt.

Description

Henrik Zetterberg reports new ways to measure blood biomarkers for Alzheimer's disease and related dementias, aimed at global studies. Recent tools can read markers in normal plasma and in dried plasma spots. A new method called NULISA was checked against the Simoa platform.

Proteins from dried spots kept at room temperature for weeks could still be read well. Markers such as P-tau217, neurofilament light and GFAP matched Simoa results closely, though spot levels were lower than in venous blood. NULISA was at least ten times as sensitive and could read three markers from one drop. Zetterberg notes that spot-specific reference limits are still needed.

Catalog record

CREATORHenrik Zetterberg
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11715700

Browse the full library · About the Tower of Babel